Cookies on this site

A new international study co-led by Professor Arri Coomarasamy of the University of Birmingham and the Nuffield Department of Women’s and Reproductive Health, University of Oxford, has shown that diagnosing postpartum haemorrhage (PPH) within the first 90 minutes after childbirth can be crucial in preventing maternal deaths.

Mother lying on a bed with a newborn

Published in The Lancet Global Health, the research, part of the large-scale E-MOTIVE cluster-randomised trial, analysed more than 2,500 births across 39 hospitals in Nigeria, Kenya, Tanzania, and South Africa. The study assessed when and how PPH is diagnosed and compared clinical approaches across different national contexts.

Understanding the Global Challenge

Postpartum haemorrhage remains the leading cause of maternal mortality worldwide, responsible for around 70,000 preventable deaths each year, according to the World Health Organization (WHO). The majority of these deaths occur in low- and middle-income countries, where delays in recognising and treating excessive bleeding are common.

Traditionally, PPH has been defined as blood loss of 500 millilitres or more within 24 hours of birth. However, evidence has long suggested that the most severe bleeding and maternal deaths occur within the first one to two hours after delivery. The new study challenges the adequacy of this traditional threshold and timing, providing real-world data to inform global re-evaluation of PPH definitions.

 

Read the full story on the Nuffield Department of Women's & Reproductive Health website.

 

 

Similar stories

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

Five European Research Council (ERC) Synergy Grants awarded to Oxford researchers for ambitious new collaborations

Five Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants support groups of two to four outstanding researchers who combine complementary expertise and resources to tackle ambitious scientific challenges that could not be addressed by individual teams alone.

Professor Ole Jensen (Department of Experimental Psychology) and colleagues received €13.6 million to discover when the brain is ready for language and social understanding

The team will use new wearable brain sensors to track cognitive development from before birth to eight years of age.

New 'molecular glue' helps break down antibiotic resistance enzymes in E. coli

Oxford University scientists have discovered a new approach to tackle antimicrobial resistance (AMR), using 'molecular glues' to encourage bacteria to destroy their own resistance-causing enzymes. The study has been published in Angewandte Chemie International Edition.

Stronger immune system may help protect against prostate cancer

Higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer, in a new study led by researchers at the Nuffield Department of Population Health.

The Nuffield Department of Women's & Reproductive Health has published its Biennial Report 2024–26

The Biennial Report 2024–26 highlights two years of research excellence, innovation, collaboration and growth.